| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nursing Homes | 87 | 2021 | 287 | 12.550 |
Why?
|
| Osteoarthritis, Knee | 11 | 2015 | 46 | 5.600 |
Why?
|
| Aged | 140 | 2017 | 7625 | 3.700 |
Why?
|
| Humans | 242 | 2021 | 33715 | 3.600 |
Why?
|
| Female | 183 | 2017 | 18871 | 3.530 |
Why?
|
| United States | 93 | 2017 | 4047 | 3.520 |
Why?
|
| Male | 163 | 2017 | 17061 | 3.340 |
Why?
|
| Sexual Partners | 6 | 2015 | 77 | 3.190 |
Why?
|
| Aged, 80 and over | 83 | 2017 | 2895 | 3.130 |
Why?
|
| Dementia | 15 | 2015 | 120 | 3.090 |
Why?
|
| Drug Utilization Review | 12 | 2015 | 53 | 2.930 |
Why?
|
| Antipsychotic Agents | 16 | 2015 | 237 | 2.690 |
Why?
|
| Pain | 12 | 2021 | 216 | 2.640 |
Why?
|
| Pain Measurement | 14 | 2021 | 202 | 2.610 |
Why?
|
| Long-Term Care | 22 | 2017 | 113 | 2.470 |
Why?
|
| Drug Utilization | 25 | 2017 | 149 | 2.330 |
Why?
|
| Homes for the Aged | 15 | 2012 | 85 | 2.310 |
Why?
|
| Cross-Sectional Studies | 49 | 2021 | 1218 | 2.250 |
Why?
|
| Contraception Behavior | 5 | 2012 | 31 | 2.200 |
Why?
|
| Attitude of Health Personnel | 7 | 2011 | 371 | 2.190 |
Why?
|
| Adult | 78 | 2017 | 9731 | 2.190 |
Why?
|
| Analgesics | 12 | 2015 | 70 | 2.180 |
Why?
|
| Complementary Therapies | 5 | 2013 | 45 | 2.150 |
Why?
|
| Pharmacists | 6 | 2011 | 45 | 2.140 |
Why?
|
| Middle Aged | 82 | 2017 | 9823 | 2.140 |
Why?
|
| Clostridium difficile | 4 | 2015 | 30 | 2.120 |
Why?
|
| Liver Cirrhosis | 4 | 2013 | 80 | 2.070 |
Why?
|
| Drug Prescriptions | 13 | 2012 | 120 | 2.060 |
Why?
|
| Logistic Models | 34 | 2017 | 906 | 1.960 |
Why?
|
| Electronic Prescribing | 4 | 2012 | 9 | 1.880 |
Why?
|
| Sulfonylurea Compounds | 3 | 2015 | 12 | 1.800 |
Why?
|
| Depression | 11 | 2017 | 406 | 1.740 |
Why?
|
| Pharmaceutical Services | 6 | 2011 | 16 | 1.710 |
Why?
|
| Alzheimer Disease | 14 | 2009 | 213 | 1.710 |
Why?
|
| Risk Factors | 52 | 2017 | 3033 | 1.690 |
Why?
|
| Activities of Daily Living | 16 | 2015 | 198 | 1.660 |
Why?
|
| Sexual Behavior | 4 | 2015 | 149 | 1.650 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 6 | 2015 | 149 | 1.650 |
Why?
|
| Hypoglycemic Agents | 6 | 2015 | 164 | 1.640 |
Why?
|
| Risk-Taking | 8 | 2015 | 147 | 1.630 |
Why?
|
| Cross Infection | 4 | 2015 | 85 | 1.590 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2017 | 144 | 1.570 |
Why?
|
| Quality Assurance, Health Care | 6 | 2015 | 214 | 1.550 |
Why?
|
| Adrenergic beta-Antagonists | 7 | 2013 | 111 | 1.540 |
Why?
|
| Psychotropic Drugs | 6 | 2015 | 56 | 1.530 |
Why?
|
| Fractures, Bone | 4 | 2015 | 110 | 1.520 |
Why?
|
| Clostridium Infections | 3 | 2012 | 16 | 1.510 |
Why?
|
| Models, Statistical | 6 | 2016 | 253 | 1.490 |
Why?
|
| Socioeconomic Factors | 18 | 2015 | 594 | 1.480 |
Why?
|
| Health Behavior | 8 | 2012 | 376 | 1.470 |
Why?
|
| Knee Joint | 4 | 2015 | 61 | 1.450 |
Why?
|
| Nurses' Aides | 4 | 2010 | 11 | 1.450 |
Why?
|
| Ethnic Groups | 6 | 2015 | 223 | 1.420 |
Why?
|
| Pregnancy, Unwanted | 3 | 2012 | 8 | 1.400 |
Why?
|
| Chondroitin | 3 | 2015 | 3 | 1.400 |
Why?
|
| Glucosamine | 3 | 2015 | 9 | 1.400 |
Why?
|
| Quality of Life | 5 | 2014 | 419 | 1.370 |
Why?
|
| Odds Ratio | 22 | 2017 | 632 | 1.370 |
Why?
|
| Accidental Falls | 6 | 2015 | 81 | 1.370 |
Why?
|
| Brain Injuries | 5 | 2014 | 82 | 1.350 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2015 | 424 | 1.300 |
Why?
|
| Obesity | 7 | 2013 | 871 | 1.300 |
Why?
|
| Continental Population Groups | 4 | 2015 | 131 | 1.290 |
Why?
|
| Contraceptive Agents, Female | 3 | 2012 | 19 | 1.280 |
Why?
|
| Young Adult | 16 | 2017 | 2216 | 1.260 |
Why?
|
| Adolescent | 30 | 2015 | 4050 | 1.250 |
Why?
|
| Depressive Disorder | 4 | 2012 | 213 | 1.240 |
Why?
|
| Frail Elderly | 8 | 2017 | 44 | 1.240 |
Why?
|
| Coitus | 3 | 2015 | 14 | 1.210 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2015 | 23 | 1.160 |
Why?
|
| Retrospective Studies | 33 | 2015 | 2640 | 1.140 |
Why?
|
| Antidepressive Agents | 12 | 2017 | 163 | 1.130 |
Why?
|
| Databases, Factual | 19 | 2015 | 417 | 1.130 |
Why?
|
| Homeless Persons | 2 | 2014 | 64 | 1.110 |
Why?
|
| Dietary Supplements | 2 | 2015 | 157 | 1.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2012 | 581 | 1.090 |
Why?
|
| Prevalence | 23 | 2017 | 813 | 1.070 |
Why?
|
| Hip Fractures | 3 | 2015 | 51 | 1.060 |
Why?
|
| Multiple Sclerosis | 2 | 2014 | 99 | 1.030 |
Why?
|
| Medicare | 12 | 2015 | 232 | 1.020 |
Why?
|
| Proton Pump Inhibitors | 2 | 2012 | 17 | 1.020 |
Why?
|
| Guideline Adherence | 5 | 2014 | 214 | 1.000 |
Why?
|
| Practice Guidelines as Topic | 6 | 2013 | 435 | 0.980 |
Why?
|
| Cohort Studies | 20 | 2015 | 1435 | 0.970 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2014 | 335 | 0.960 |
Why?
|
| Age Factors | 19 | 2015 | 1102 | 0.960 |
Why?
|
| Behavioral Risk Factor Surveillance System | 3 | 2013 | 44 | 0.950 |
Why?
|
| Confidence Intervals | 14 | 2015 | 250 | 0.930 |
Why?
|
| Ambulatory Care | 2 | 2014 | 206 | 0.930 |
Why?
|
| European Continental Ancestry Group | 7 | 2014 | 438 | 0.930 |
Why?
|
| Medication Errors | 5 | 2012 | 93 | 0.920 |
Why?
|
| Medical Order Entry Systems | 4 | 2010 | 37 | 0.920 |
Why?
|
| Stroke | 9 | 2017 | 471 | 0.910 |
Why?
|
| Overweight | 3 | 2013 | 177 | 0.910 |
Why?
|
| Prospective Payment System | 4 | 2006 | 6 | 0.900 |
Why?
|
| Diabetes Mellitus | 5 | 2011 | 393 | 0.900 |
Why?
|
| Clinical Pharmacy Information Systems | 2 | 2012 | 9 | 0.900 |
Why?
|
| African Americans | 6 | 2014 | 394 | 0.890 |
Why?
|
| Proportional Hazards Models | 13 | 2015 | 457 | 0.850 |
Why?
|
| Hospitalization | 15 | 2014 | 648 | 0.820 |
Why?
|
| Mental Disorders | 2 | 2014 | 467 | 0.820 |
Why?
|
| Polypharmacy | 5 | 2012 | 28 | 0.810 |
Why?
|
| Exercise | 5 | 2015 | 517 | 0.810 |
Why?
|
| Cholinesterase Inhibitors | 5 | 2010 | 25 | 0.800 |
Why?
|
| Professional Role | 3 | 2007 | 29 | 0.790 |
Why?
|
| Antihypertensive Agents | 6 | 2010 | 110 | 0.790 |
Why?
|
| Consultants | 3 | 2006 | 12 | 0.780 |
Why?
|
| Job Satisfaction | 3 | 2010 | 74 | 0.770 |
Why?
|
| Physicians | 2 | 2011 | 216 | 0.770 |
Why?
|
| Body Mass Index | 9 | 2014 | 709 | 0.750 |
Why?
|
| Gastrointestinal Diseases | 2 | 2013 | 60 | 0.750 |
Why?
|
| Alcohol Drinking | 4 | 2008 | 207 | 0.750 |
Why?
|
| Anti-Bacterial Agents | 3 | 2012 | 376 | 0.740 |
Why?
|
| Models, Theoretical | 5 | 2013 | 202 | 0.740 |
Why?
|
| Myocardial Infarction | 7 | 2015 | 721 | 0.730 |
Why?
|
| Data Collection | 7 | 2010 | 354 | 0.720 |
Why?
|
| Case-Control Studies | 17 | 2012 | 654 | 0.720 |
Why?
|
| Sex Factors | 19 | 2015 | 661 | 0.720 |
Why?
|
| Parkinson Disease | 4 | 2002 | 55 | 0.720 |
Why?
|
| Comorbidity | 16 | 2015 | 721 | 0.720 |
Why?
|
| Treatment Outcome | 12 | 2015 | 2602 | 0.710 |
Why?
|
| Nursing Staff | 2 | 2007 | 31 | 0.690 |
Why?
|
| Aging | 3 | 2013 | 513 | 0.690 |
Why?
|
| Process Assessment (Health Care) | 3 | 2006 | 36 | 0.690 |
Why?
|
| Drug Therapy | 2 | 2007 | 49 | 0.690 |
Why?
|
| Indans | 3 | 2005 | 5 | 0.680 |
Why?
|
| Software | 2 | 2010 | 242 | 0.680 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 34 | 0.680 |
Why?
|
| Causality | 1 | 2016 | 41 | 0.680 |
Why?
|
| Safety | 2 | 2007 | 119 | 0.670 |
Why?
|
| Population Surveillance | 8 | 2013 | 185 | 0.670 |
Why?
|
| Electronic Health Records | 3 | 2015 | 123 | 0.670 |
Why?
|
| Piperidines | 3 | 2005 | 31 | 0.670 |
Why?
|
| Health Surveys | 4 | 2014 | 264 | 0.670 |
Why?
|
| Medication Adherence | 3 | 2015 | 155 | 0.670 |
Why?
|
| Urban Population | 2 | 2015 | 163 | 0.660 |
Why?
|
| Patient Compliance | 4 | 2014 | 291 | 0.650 |
Why?
|
| Off-Label Use | 1 | 2015 | 9 | 0.650 |
Why?
|
| Intention to Treat Analysis | 1 | 2015 | 6 | 0.640 |
Why?
|
| Citalopram | 1 | 2015 | 10 | 0.640 |
Why?
|
| Abdominal Pain | 1 | 2015 | 48 | 0.630 |
Why?
|
| Osteoarthritis | 1 | 2015 | 30 | 0.630 |
Why?
|
| Dyslipidemias | 1 | 2015 | 24 | 0.630 |
Why?
|
| Severity of Illness Index | 10 | 2017 | 860 | 0.620 |
Why?
|
| Risk Assessment | 13 | 2017 | 1070 | 0.620 |
Why?
|
| Analgesics, Opioid | 5 | 2013 | 169 | 0.620 |
Why?
|
| Medicaid | 12 | 2013 | 164 | 0.620 |
Why?
|
| Community-Acquired Infections | 1 | 2015 | 45 | 0.610 |
Why?
|
| Contraception | 2 | 2012 | 29 | 0.610 |
Why?
|
| Abstracting and Indexing as Topic | 2 | 2014 | 14 | 0.610 |
Why?
|
| Physician-Patient Relations | 2 | 2007 | 280 | 0.610 |
Why?
|
| Body Weight | 3 | 2014 | 345 | 0.600 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2012 | 47 | 0.600 |
Why?
|
| Skilled Nursing Facilities | 2 | 2006 | 30 | 0.600 |
Why?
|
| Sedentary Lifestyle | 1 | 2015 | 67 | 0.600 |
Why?
|
| Documentation | 2 | 2014 | 56 | 0.600 |
Why?
|
| Residence Characteristics | 2 | 2013 | 165 | 0.600 |
Why?
|
| Mortality | 1 | 2015 | 83 | 0.590 |
Why?
|
| Metabolic Syndrome X | 1 | 2015 | 103 | 0.590 |
Why?
|
| Biomedical Research | 2 | 2014 | 141 | 0.590 |
Why?
|
| Violence | 3 | 2013 | 138 | 0.580 |
Why?
|
| Writing | 1 | 2014 | 35 | 0.580 |
Why?
|
| Internet | 2 | 2015 | 363 | 0.580 |
Why?
|
| Heterosexuality | 1 | 2014 | 16 | 0.580 |
Why?
|
| Publishing | 1 | 2014 | 52 | 0.580 |
Why?
|
| Smoking | 9 | 2015 | 737 | 0.580 |
Why?
|
| Homosexuality, Female | 1 | 2014 | 18 | 0.570 |
Why?
|
| Pharmacoepidemiology | 1 | 2014 | 9 | 0.570 |
Why?
|
| Information Dissemination | 2 | 2014 | 81 | 0.570 |
Why?
|
| Research Personnel | 1 | 2014 | 53 | 0.570 |
Why?
|
| Health Services Accessibility | 2 | 2015 | 297 | 0.570 |
Why?
|
| Appointments and Schedules | 1 | 2014 | 32 | 0.560 |
Why?
|
| Menarche | 1 | 2013 | 39 | 0.560 |
Why?
|
| Neuralgia | 1 | 2013 | 8 | 0.560 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 117 | 0.560 |
Why?
|
| Health Status Disparities | 2 | 2013 | 77 | 0.560 |
Why?
|
| Incidence | 9 | 2015 | 819 | 0.560 |
Why?
|
| Intestinal Absorption | 1 | 2013 | 27 | 0.560 |
Why?
|
| Computer Simulation | 1 | 2015 | 306 | 0.560 |
Why?
|
| Comprehension | 1 | 2014 | 81 | 0.560 |
Why?
|
| Cell Membrane Permeability | 1 | 2013 | 31 | 0.560 |
Why?
|
| Preventive Health Services | 2 | 2013 | 43 | 0.550 |
Why?
|
| Skin Neoplasms | 4 | 2011 | 231 | 0.550 |
Why?
|
| Drug Interactions | 3 | 2008 | 85 | 0.550 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2010 | 37 | 0.540 |
Why?
|
| Algorithms | 6 | 2017 | 640 | 0.540 |
Why?
|
| Psychiatry | 1 | 2014 | 66 | 0.540 |
Why?
|
| Outpatients | 1 | 2013 | 61 | 0.540 |
Why?
|
| Infection | 1 | 2013 | 58 | 0.540 |
Why?
|
| Disease Progression | 4 | 2015 | 473 | 0.530 |
Why?
|
| Thiazolidinediones | 2 | 2013 | 50 | 0.530 |
Why?
|
| Cognition | 9 | 2012 | 212 | 0.530 |
Why?
|
| Spouse Abuse | 1 | 2013 | 34 | 0.530 |
Why?
|
| Follow-Up Studies | 13 | 2015 | 1520 | 0.530 |
Why?
|
| Videodisc Recording | 1 | 2012 | 7 | 0.530 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2009 | 98 | 0.520 |
Why?
|
| Mandatory Programs | 1 | 2012 | 14 | 0.510 |
Why?
|
| Interleukin-6 | 1 | 2013 | 219 | 0.510 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2012 | 22 | 0.510 |
Why?
|
| Gonorrhea | 1 | 2013 | 99 | 0.510 |
Why?
|
| Motor Activity | 1 | 2015 | 305 | 0.510 |
Why?
|
| Coffee | 1 | 2012 | 10 | 0.510 |
Why?
|
| Women's Health | 4 | 2012 | 302 | 0.510 |
Why?
|
| Bacteremia | 1 | 2012 | 56 | 0.510 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 6 | 2008 | 101 | 0.500 |
Why?
|
| Mass Screening | 3 | 2013 | 344 | 0.500 |
Why?
|
| Decompressive Craniectomy | 1 | 2012 | 3 | 0.500 |
Why?
|
| Monitoring, Physiologic | 2 | 2017 | 104 | 0.500 |
Why?
|
| Caffeine | 1 | 2012 | 42 | 0.500 |
Why?
|
| Drug Therapy, Computer-Assisted | 2 | 2010 | 12 | 0.500 |
Why?
|
| Pregnancy | 8 | 2017 | 1238 | 0.500 |
Why?
|
| Perception | 2 | 2014 | 86 | 0.500 |
Why?
|
| Health Services Research | 7 | 2014 | 215 | 0.500 |
Why?
|
| Abortion, Induced | 1 | 2012 | 15 | 0.500 |
Why?
|
| Pregnancy, Unplanned | 1 | 2012 | 15 | 0.500 |
Why?
|
| Communication | 3 | 2012 | 268 | 0.490 |
Why?
|
| Cardiovascular Diseases | 13 | 2009 | 512 | 0.490 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 711 | 0.490 |
Why?
|
| Radiography | 4 | 2013 | 282 | 0.490 |
Why?
|
| Sex Distribution | 9 | 2012 | 212 | 0.480 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 60 | 0.480 |
Why?
|
| Age Distribution | 8 | 2012 | 222 | 0.470 |
Why?
|
| Health Promotion | 2 | 2011 | 360 | 0.470 |
Why?
|
| Cognitive Therapy | 1 | 2012 | 84 | 0.470 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 396 | 0.470 |
Why?
|
| Health Education | 1 | 2012 | 174 | 0.470 |
Why?
|
| Public Housing | 1 | 2011 | 5 | 0.470 |
Why?
|
| Terminal Care | 2 | 2011 | 46 | 0.460 |
Why?
|
| Coronary Disease | 10 | 2002 | 338 | 0.460 |
Why?
|
| Selection Bias | 1 | 2010 | 20 | 0.460 |
Why?
|
| Prospective Studies | 10 | 2017 | 1657 | 0.450 |
Why?
|
| Fatigue | 1 | 2011 | 56 | 0.450 |
Why?
|
| Software Validation | 1 | 2010 | 5 | 0.450 |
Why?
|
| Neoplasms | 2 | 2015 | 586 | 0.440 |
Why?
|
| Withholding Treatment | 1 | 2010 | 21 | 0.440 |
Why?
|
| Models, Organizational | 1 | 2010 | 76 | 0.440 |
Why?
|
| Work Schedule Tolerance | 1 | 2010 | 24 | 0.440 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 582 | 0.440 |
Why?
|
| Adolescent Behavior | 1 | 2011 | 161 | 0.430 |
Why?
|
| Vulnerable Populations | 1 | 2010 | 55 | 0.430 |
Why?
|
| Program Evaluation | 3 | 2010 | 312 | 0.430 |
Why?
|
| Primary Health Care | 2 | 2011 | 402 | 0.420 |
Why?
|
| Personnel Staffing and Scheduling | 3 | 2006 | 54 | 0.420 |
Why?
|
| User-Computer Interface | 1 | 2010 | 106 | 0.420 |
Why?
|
| Prescription Drugs | 2 | 2013 | 37 | 0.410 |
Why?
|
| Fathers | 1 | 2009 | 20 | 0.410 |
Why?
|
| Poverty | 1 | 2011 | 217 | 0.410 |
Why?
|
| Aspirin | 6 | 2003 | 137 | 0.410 |
Why?
|
| Residential Facilities | 1 | 2009 | 18 | 0.410 |
Why?
|
| Rhode Island | 14 | 2010 | 83 | 0.410 |
Why?
|
| Time Factors | 15 | 2017 | 2573 | 0.410 |
Why?
|
| Motor Skills | 1 | 2009 | 48 | 0.400 |
Why?
|
| Carrier Proteins | 1 | 2013 | 588 | 0.400 |
Why?
|
| Safety Management | 2 | 2006 | 119 | 0.390 |
Why?
|
| Cognition Disorders | 9 | 2012 | 171 | 0.390 |
Why?
|
| Psychotic Disorders | 2 | 2006 | 108 | 0.390 |
Why?
|
| Caregivers | 1 | 2009 | 80 | 0.390 |
Why?
|
| Myocardial Ischemia | 2 | 2002 | 108 | 0.390 |
Why?
|
| Nootropic Agents | 2 | 2005 | 7 | 0.380 |
Why?
|
| Stress, Psychological | 3 | 2011 | 270 | 0.380 |
Why?
|
| Nursing Faculty Practice | 1 | 2008 | 2 | 0.380 |
Why?
|
| Tacrine | 3 | 2005 | 3 | 0.380 |
Why?
|
| Attitude to Computers | 1 | 2008 | 29 | 0.380 |
Why?
|
| Evidence-Based Medicine | 4 | 2017 | 280 | 0.380 |
Why?
|
| Organizational Culture | 6 | 2011 | 66 | 0.370 |
Why?
|
| Risk | 5 | 2015 | 344 | 0.370 |
Why?
|
| Reminder Systems | 1 | 2008 | 41 | 0.370 |
Why?
|
| Sex Characteristics | 2 | 2015 | 132 | 0.370 |
Why?
|
| Arthritis | 2 | 2013 | 35 | 0.370 |
Why?
|
| Quality of Health Care | 7 | 2015 | 354 | 0.370 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2007 | 17 | 0.370 |
Why?
|
| Hypertension | 8 | 2005 | 365 | 0.360 |
Why?
|
| Drug and Narcotic Control | 1 | 2007 | 27 | 0.360 |
Why?
|
| Ketolides | 1 | 2007 | 2 | 0.350 |
Why?
|
| Outcome Assessment (Health Care) | 6 | 2013 | 386 | 0.350 |
Why?
|
| Diuretics | 4 | 2003 | 32 | 0.350 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2013 | 264 | 0.350 |
Why?
|
| Heart Failure | 6 | 2002 | 457 | 0.350 |
Why?
|
| Community Pharmacy Services | 1 | 2006 | 8 | 0.340 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 154 | 0.340 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 163 | 0.340 |
Why?
|
| Burnout, Professional | 1 | 2006 | 20 | 0.340 |
Why?
|
| Substance-Related Disorders | 3 | 2007 | 400 | 0.340 |
Why?
|
| Pregnancy in Adolescence | 1 | 2006 | 20 | 0.340 |
Why?
|
| Hospice Care | 2 | 2006 | 20 | 0.340 |
Why?
|
| Parity | 1 | 2006 | 43 | 0.340 |
Why?
|
| Telemedicine | 1 | 2007 | 85 | 0.340 |
Why?
|
| Nurses | 1 | 2006 | 44 | 0.330 |
Why?
|
| Liver Diseases | 1 | 2007 | 93 | 0.330 |
Why?
|
| Geriatrics | 3 | 2011 | 27 | 0.320 |
Why?
|
| Referral and Consultation | 2 | 2006 | 227 | 0.320 |
Why?
|
| Hispanic Americans | 3 | 2010 | 401 | 0.320 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2014 | 72 | 0.320 |
Why?
|
| Pressure Ulcer | 1 | 2005 | 24 | 0.310 |
Why?
|
| Weight Loss | 3 | 2014 | 201 | 0.310 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 271 | 0.310 |
Why?
|
| Chronic Disease | 5 | 2011 | 530 | 0.310 |
Why?
|
| Geriatric Assessment | 8 | 2013 | 87 | 0.300 |
Why?
|
| Virginia | 2 | 2014 | 11 | 0.300 |
Why?
|
| Benzodiazepines | 5 | 2008 | 68 | 0.300 |
Why?
|
| Efficiency, Organizational | 1 | 2005 | 60 | 0.290 |
Why?
|
| Health Status | 8 | 2014 | 314 | 0.290 |
Why?
|
| Bias (Epidemiology) | 4 | 2016 | 68 | 0.290 |
Why?
|
| Private Sector | 1 | 2004 | 12 | 0.290 |
Why?
|
| Life Style | 7 | 2015 | 262 | 0.290 |
Why?
|
| Public Sector | 1 | 2004 | 18 | 0.290 |
Why?
|
| Quality Indicators, Health Care | 5 | 2015 | 247 | 0.290 |
Why?
|
| Neck Pain | 2 | 2014 | 10 | 0.280 |
Why?
|
| Women's Health Services | 1 | 2004 | 29 | 0.280 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2004 | 37 | 0.280 |
Why?
|
| Reference Values | 3 | 2015 | 309 | 0.280 |
Why?
|
| Medical Informatics | 2 | 2015 | 53 | 0.280 |
Why?
|
| Oxycodone | 2 | 2014 | 15 | 0.280 |
Why?
|
| Fever | 1 | 2004 | 57 | 0.280 |
Why?
|
| Hysterectomy | 1 | 2004 | 48 | 0.280 |
Why?
|
| Longitudinal Studies | 3 | 2015 | 695 | 0.280 |
Why?
|
| Pain, Postoperative | 2 | 2014 | 61 | 0.270 |
Why?
|
| Military Personnel | 2 | 2013 | 42 | 0.270 |
Why?
|
| Cultural Diversity | 2 | 2013 | 37 | 0.270 |
Why?
|
| Registries | 2 | 2017 | 461 | 0.270 |
Why?
|
| Homocysteine | 6 | 1999 | 47 | 0.260 |
Why?
|
| Interviews as Topic | 4 | 2009 | 331 | 0.260 |
Why?
|
| Estrogens | 2 | 2002 | 101 | 0.260 |
Why?
|
| Patient Admission | 4 | 2015 | 97 | 0.260 |
Why?
|
| Serotonin Uptake Inhibitors | 3 | 2017 | 105 | 0.250 |
Why?
|
| Income | 2 | 2013 | 88 | 0.240 |
Why?
|
| Gastrointestinal Agents | 1 | 2001 | 13 | 0.240 |
Why?
|
| Digestive System | 1 | 2001 | 26 | 0.240 |
Why?
|
| Glasgow Outcome Scale | 2 | 2011 | 6 | 0.230 |
Why?
|
| Attitude to Health | 3 | 2012 | 257 | 0.230 |
Why?
|
| Ownership | 4 | 2013 | 7 | 0.230 |
Why?
|
| Patient Discharge | 5 | 2015 | 225 | 0.230 |
Why?
|
| Geriatric Nursing | 2 | 2011 | 41 | 0.230 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2000 | 84 | 0.220 |
Why?
|
| Centers for Medicare and Medicaid Services (U.S.) | 4 | 2012 | 33 | 0.220 |
Why?
|
| Tretinoin | 2 | 2011 | 37 | 0.220 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 677 | 0.220 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 784 | 0.210 |
Why?
|
| Clinical Trials as Topic | 3 | 2013 | 295 | 0.210 |
Why?
|
| Survival Analysis | 7 | 2013 | 375 | 0.210 |
Why?
|
| Postoperative Complications | 1 | 2004 | 611 | 0.210 |
Why?
|
| Inpatients | 1 | 2001 | 152 | 0.210 |
Why?
|
| North Carolina | 2 | 2010 | 33 | 0.200 |
Why?
|
| Medically Uninsured | 2 | 2012 | 32 | 0.200 |
Why?
|
| Health Services for the Aged | 3 | 2007 | 37 | 0.200 |
Why?
|
| Renal Dialysis | 5 | 1999 | 142 | 0.200 |
Why?
|
| Weight Gain | 2 | 2010 | 151 | 0.190 |
Why?
|
| Research Design | 4 | 2014 | 377 | 0.190 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2009 | 46 | 0.190 |
Why?
|
| Cardiovascular Agents | 2 | 2015 | 73 | 0.190 |
Why?
|
| Marital Status | 2 | 2010 | 31 | 0.190 |
Why?
|
| Ontario | 2 | 2017 | 22 | 0.190 |
Why?
|
| Ischemia | 1 | 1999 | 126 | 0.190 |
Why?
|
| Drug Administration Schedule | 4 | 2012 | 216 | 0.190 |
Why?
|
| Pharmaceutical Preparations | 3 | 2007 | 70 | 0.180 |
Why?
|
| Deficiency Diseases | 1 | 2017 | 9 | 0.180 |
Why?
|
| Maternal Exposure | 1 | 2017 | 26 | 0.180 |
Why?
|
| Iodine | 1 | 2017 | 16 | 0.180 |
Why?
|
| Patient Care Management | 1 | 2017 | 13 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2010 | 499 | 0.180 |
Why?
|
| Pre-Eclampsia | 1 | 2017 | 31 | 0.180 |
Why?
|
| Personnel Turnover | 2 | 2007 | 11 | 0.180 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 223 | 0.180 |
Why?
|
| Focus Groups | 2 | 2008 | 183 | 0.180 |
Why?
|
| Hepatitis C | 1 | 1998 | 99 | 0.180 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 73 | 0.170 |
Why?
|
| Half-Life | 2 | 2015 | 56 | 0.170 |
Why?
|
| Nutrition Surveys | 3 | 2017 | 100 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 5 | 2009 | 42 | 0.170 |
Why?
|
| Professional Autonomy | 2 | 2006 | 12 | 0.170 |
Why?
|
| Prognosis | 7 | 2015 | 910 | 0.170 |
Why?
|
| Tryptamines | 1 | 2015 | 5 | 0.160 |
Why?
|
| Workload | 2 | 2006 | 65 | 0.160 |
Why?
|
| Affect | 5 | 2009 | 77 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 651 | 0.160 |
Why?
|
| Psychometrics | 2 | 2013 | 249 | 0.160 |
Why?
|
| Internal-External Control | 1 | 2015 | 37 | 0.160 |
Why?
|
| Bulimia | 1 | 2015 | 7 | 0.160 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 15 | 0.160 |
Why?
|
| Drug Combinations | 2 | 2015 | 101 | 0.160 |
Why?
|
| Phobic Disorders | 1 | 2015 | 19 | 0.160 |
Why?
|
| Personality Inventory | 1 | 2015 | 57 | 0.160 |
Why?
|
| Nurse's Role | 2 | 2006 | 93 | 0.160 |
Why?
|
| Infertility, Female | 1 | 1995 | 40 | 0.160 |
Why?
|
| Child Behavior Disorders | 1 | 2015 | 33 | 0.160 |
Why?
|
| Child | 5 | 2014 | 2699 | 0.160 |
Why?
|
| Ohio | 2 | 2006 | 17 | 0.160 |
Why?
|
| Femoral Fractures | 3 | 2007 | 19 | 0.160 |
Why?
|
| Knee | 1 | 2015 | 13 | 0.150 |
Why?
|
| Information Seeking Behavior | 1 | 2015 | 26 | 0.150 |
Why?
|
| Palliative Care | 2 | 2010 | 70 | 0.150 |
Why?
|
| Health Care Surveys | 2 | 2007 | 234 | 0.150 |
Why?
|
| Hypoglycemia | 1 | 2015 | 35 | 0.150 |
Why?
|
| Anti-Anxiety Agents | 4 | 2008 | 27 | 0.150 |
Why?
|
| Peer Review, Research | 1 | 2014 | 27 | 0.150 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2013 | 213 | 0.150 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 85 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 228 | 0.150 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 92 | 0.150 |
Why?
|
| Cluster Analysis | 2 | 2012 | 200 | 0.150 |
Why?
|
| Insurance Claim Reporting | 2 | 2006 | 19 | 0.150 |
Why?
|
| Interpersonal Relations | 2 | 2013 | 106 | 0.150 |
Why?
|
| Milk | 1 | 2014 | 34 | 0.150 |
Why?
|
| Tibia | 1 | 2014 | 27 | 0.150 |
Why?
|
| Femur | 1 | 2014 | 31 | 0.140 |
Why?
|
| Community Mental Health Centers | 1 | 2014 | 20 | 0.140 |
Why?
|
| Fatty Acids | 1 | 1995 | 134 | 0.140 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 158 | 0.140 |
Why?
|
| Manipulation, Chiropractic | 1 | 2013 | 2 | 0.140 |
Why?
|
| Physical Therapy Modalities | 1 | 2014 | 31 | 0.140 |
Why?
|
| Manipulation, Orthopedic | 1 | 2013 | 5 | 0.140 |
Why?
|
| Reproducibility of Results | 7 | 2010 | 995 | 0.140 |
Why?
|
| Epidemiologic Methods | 1 | 2013 | 68 | 0.140 |
Why?
|
| Metronidazole | 1 | 2013 | 7 | 0.140 |
Why?
|
| Dietary Fats | 1 | 1995 | 201 | 0.140 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2013 | 4 | 0.140 |
Why?
|
| Medicare Part D | 1 | 2013 | 14 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2015 | 174 | 0.140 |
Why?
|
| Cannabinoids | 1 | 2013 | 25 | 0.140 |
Why?
|
| Osteoporosis | 2 | 2006 | 111 | 0.140 |
Why?
|
| Anticonvulsants | 1 | 2013 | 43 | 0.140 |
Why?
|
| Back Pain | 1 | 2013 | 24 | 0.140 |
Why?
|
| Constipation | 1 | 2013 | 13 | 0.140 |
Why?
|
| Medical History Taking | 2 | 2017 | 46 | 0.140 |
Why?
|
| Nausea | 1 | 2013 | 21 | 0.140 |
Why?
|
| Arthralgia | 1 | 2013 | 32 | 0.140 |
Why?
|
| Single-Blind Method | 2 | 2011 | 76 | 0.140 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 77 | 0.140 |
Why?
|
| Housing | 1 | 2013 | 31 | 0.140 |
Why?
|
| Schizophrenia | 1 | 2015 | 218 | 0.140 |
Why?
|
| Baltimore | 1 | 2013 | 15 | 0.140 |
Why?
|
| Vomiting | 1 | 2013 | 30 | 0.130 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 161 | 0.130 |
Why?
|
| Drug Monitoring | 2 | 2011 | 90 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 175 | 0.130 |
Why?
|
| Metformin | 1 | 2013 | 37 | 0.130 |
Why?
|
| Secondary Prevention | 3 | 2015 | 88 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 249 | 0.130 |
Why?
|
| Histamine H2 Antagonists | 1 | 2012 | 8 | 0.130 |
Why?
|
| Syndrome | 1 | 2013 | 119 | 0.130 |
Why?
|
| Gastric Acid | 1 | 2012 | 14 | 0.130 |
Why?
|
| Behavior Therapy | 1 | 2014 | 127 | 0.130 |
Why?
|
| Health Facilities, Proprietary | 2 | 2013 | 8 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 69 | 0.130 |
Why?
|
| Schistosoma japonicum | 1 | 2012 | 1 | 0.130 |
Why?
|
| Schistosomiasis japonica | 1 | 2012 | 1 | 0.130 |
Why?
|
| Praziquantel | 1 | 2012 | 2 | 0.130 |
Why?
|
| Economic Competition | 2 | 2013 | 7 | 0.130 |
Why?
|
| Parents | 1 | 2014 | 183 | 0.130 |
Why?
|
| Drug Therapy, Combination | 6 | 2003 | 316 | 0.130 |
Why?
|
| State Government | 1 | 2012 | 28 | 0.130 |
Why?
|
| Keratinocytes | 2 | 2011 | 34 | 0.130 |
Why?
|
| Recurrence | 1 | 2013 | 396 | 0.130 |
Why?
|
| Workplace | 2 | 2006 | 117 | 0.130 |
Why?
|
| Heptanoic Acids | 1 | 2012 | 18 | 0.130 |
Why?
|
| Hospitals, Veterans | 1 | 2013 | 127 | 0.130 |
Why?
|
| Anthelmintics | 1 | 2012 | 15 | 0.130 |
Why?
|
| Simvastatin | 1 | 2012 | 16 | 0.130 |
Why?
|
| Insurance Coverage | 1 | 2012 | 58 | 0.120 |
Why?
|
| Pyrroles | 1 | 2012 | 49 | 0.120 |
Why?
|
| Empirical Research | 1 | 2011 | 14 | 0.120 |
Why?
|
| Risk Reduction Behavior | 2 | 2010 | 101 | 0.120 |
Why?
|
| Software Design | 1 | 2011 | 16 | 0.120 |
Why?
|
| Minority Groups | 3 | 2002 | 70 | 0.120 |
Why?
|
| Massachusetts | 7 | 2015 | 1451 | 0.120 |
Why?
|
| Pharmacies | 1 | 2011 | 23 | 0.120 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 162 | 0.120 |
Why?
|
| Pain, Intractable | 1 | 2011 | 6 | 0.120 |
Why?
|
| Peer Group | 1 | 2011 | 56 | 0.120 |
Why?
|
| Sickness Impact Profile | 1 | 2011 | 30 | 0.120 |
Why?
|
| Delirium | 1 | 2011 | 28 | 0.120 |
Why?
|
| Personal Satisfaction | 1 | 2011 | 38 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 3 | 1996 | 113 | 0.120 |
Why?
|
| Censuses | 1 | 2010 | 7 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 167 | 0.120 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 387 | 0.110 |
Why?
|
| Anticoagulants | 2 | 2003 | 209 | 0.110 |
Why?
|
| Antiparkinson Agents | 1 | 2010 | 1 | 0.110 |
Why?
|
| Tranquilizing Agents | 1 | 2010 | 2 | 0.110 |
Why?
|
| Carcinoma | 1 | 2011 | 97 | 0.110 |
Why?
|
| Chi-Square Distribution | 3 | 2017 | 362 | 0.110 |
Why?
|
| Anecdotes as Topic | 1 | 2010 | 11 | 0.110 |
Why?
|
| Anticholesteremic Agents | 1 | 2010 | 32 | 0.110 |
Why?
|
| Veterans | 1 | 2012 | 239 | 0.110 |
Why?
|
| Northern Ireland | 1 | 2009 | 1 | 0.110 |
Why?
|
| Digoxin | 2 | 2000 | 10 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2002 | 176 | 0.110 |
Why?
|
| Nursing Administration Research | 2 | 2008 | 7 | 0.110 |
Why?
|
| Parkinsonian Disorders | 1 | 2009 | 7 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2010 | 70 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2015 | 1318 | 0.100 |
Why?
|
| Dementia, Vascular | 2 | 1999 | 7 | 0.100 |
Why?
|
| Smoking Cessation | 2 | 2003 | 386 | 0.100 |
Why?
|
| Behavior | 1 | 2009 | 36 | 0.100 |
Why?
|
| Specialties, Nursing | 1 | 2008 | 5 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 270 | 0.100 |
Why?
|
| Alcoholic Intoxication | 1 | 2008 | 19 | 0.100 |
Why?
|
| Self Administration | 1 | 2008 | 36 | 0.100 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 22 | 0.100 |
Why?
|
| Vaginosis, Bacterial | 1 | 2008 | 15 | 0.100 |
Why?
|
| Physician Assistants | 1 | 2008 | 18 | 0.100 |
Why?
|
| Home Care Agencies | 1 | 2008 | 1 | 0.100 |
Why?
|
| Voluntary Health Agencies | 1 | 2008 | 3 | 0.100 |
Why?
|
| Prenatal Care | 1 | 2009 | 111 | 0.090 |
Why?
|
| Confounding Factors (Epidemiology) | 5 | 2009 | 54 | 0.090 |
Why?
|
| Diagnosis-Related Groups | 2 | 2001 | 79 | 0.090 |
Why?
|
| Postal Service | 1 | 2007 | 6 | 0.090 |
Why?
|
| Databases as Topic | 4 | 2002 | 53 | 0.090 |
Why?
|
| Physicians, Family | 1 | 2008 | 66 | 0.090 |
Why?
|
| Pharmacogenetics | 1 | 2007 | 15 | 0.090 |
Why?
|
| Unsafe Sex | 1 | 2007 | 23 | 0.090 |
Why?
|
| Nurse Practitioners | 1 | 2008 | 73 | 0.090 |
Why?
|
| Hospices | 2 | 2005 | 15 | 0.090 |
Why?
|
| New York | 3 | 2002 | 64 | 0.090 |
Why?
|
| HIV Infections | 1 | 2013 | 696 | 0.090 |
Why?
|
| Government Regulation | 1 | 2007 | 34 | 0.090 |
Why?
|
| Mammography | 1 | 2009 | 194 | 0.090 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2004 | 19 | 0.090 |
Why?
|
| Norway | 2 | 2017 | 6 | 0.090 |
Why?
|
| Warfarin | 3 | 2003 | 78 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2007 | 95 | 0.090 |
Why?
|
| Patient Care Planning | 1 | 2006 | 50 | 0.090 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2006 | 16 | 0.090 |
Why?
|
| Cause of Death | 2 | 2009 | 117 | 0.090 |
Why?
|
| Physical Fitness | 2 | 1999 | 101 | 0.090 |
Why?
|
| Conflict (Psychology) | 1 | 2006 | 17 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2008 | 166 | 0.080 |
Why?
|
| Contraceptives, Oral | 2 | 1996 | 22 | 0.080 |
Why?
|
| Bed Occupancy | 1 | 2006 | 13 | 0.080 |
Why?
|
| Health Facility Size | 1 | 2006 | 17 | 0.080 |
Why?
|
| Certification | 1 | 2006 | 22 | 0.080 |
Why?
|
| Clinical Competence | 2 | 2006 | 378 | 0.080 |
Why?
|
| Personal Health Services | 1 | 2005 | 2 | 0.080 |
Why?
|
| Self Efficacy | 1 | 2006 | 134 | 0.080 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 111 | 0.080 |
Why?
|
| Decision Making | 2 | 2007 | 204 | 0.080 |
Why?
|
| Nursing Assessment | 1 | 2005 | 35 | 0.080 |
Why?
|
| Alcoholism | 1 | 2007 | 181 | 0.080 |
Why?
|
| Thromboembolism | 1 | 2005 | 41 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 333 | 0.080 |
Why?
|
| Mobility Limitation | 1 | 2005 | 22 | 0.080 |
Why?
|
| South Dakota | 2 | 2002 | 5 | 0.080 |
Why?
|
| Maine | 2 | 2002 | 14 | 0.080 |
Why?
|
| Dipyridamole | 2 | 2003 | 46 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 89 | 0.080 |
Why?
|
| Perimenopause | 1 | 2004 | 23 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2005 | 69 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2005 | 68 | 0.070 |
Why?
|
| New England | 7 | 2000 | 195 | 0.070 |
Why?
|
| Ticlopidine | 2 | 2003 | 57 | 0.070 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2004 | 4 | 0.070 |
Why?
|
| Diffusion of Innovation | 1 | 2004 | 43 | 0.070 |
Why?
|
| Medical Assistance | 1 | 2004 | 7 | 0.070 |
Why?
|
| Animals | 3 | 2014 | 14079 | 0.070 |
Why?
|
| Prejudice | 1 | 2003 | 45 | 0.070 |
Why?
|
| Needs Assessment | 1 | 2004 | 108 | 0.070 |
Why?
|
| Medical Records | 1 | 2004 | 129 | 0.070 |
Why?
|
| Chromosomes, Human, Y | 1 | 2003 | 5 | 0.070 |
Why?
|
| Research | 1 | 2004 | 134 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 698 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2004 | 111 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 1 | 2003 | 59 | 0.070 |
Why?
|
| Thiocyanates | 1 | 2002 | 14 | 0.070 |
Why?
|
| Cotinine | 1 | 2002 | 15 | 0.070 |
Why?
|
| Professional-Patient Relations | 1 | 2004 | 120 | 0.070 |
Why?
|
| Cholesterol | 4 | 1999 | 219 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 2002 | 45 | 0.060 |
Why?
|
| Sensation Disorders | 1 | 2002 | 10 | 0.060 |
Why?
|
| Pneumonia, Aspiration | 1 | 2002 | 11 | 0.060 |
Why?
|
| Respiration Disorders | 1 | 2002 | 14 | 0.060 |
Why?
|
| Calcium Channel Blockers | 2 | 1999 | 50 | 0.060 |
Why?
|
| Cholesterol, HDL | 3 | 1997 | 77 | 0.060 |
Why?
|
| Economics, Hospital | 1 | 2002 | 13 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2013 | 172 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2003 | 160 | 0.060 |
Why?
|
| Bipolar Disorder | 1 | 2003 | 180 | 0.060 |
Why?
|
| Regression Analysis | 4 | 2007 | 430 | 0.060 |
Why?
|
| Patient Selection | 1 | 2003 | 283 | 0.060 |
Why?
|
| Minnesota | 1 | 2001 | 16 | 0.060 |
Why?
|
| Hypercholesterolemia | 2 | 1999 | 63 | 0.060 |
Why?
|
| Facility Regulation and Control | 1 | 2000 | 6 | 0.060 |
Why?
|
| Managed Care Programs | 1 | 2001 | 81 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2001 | 154 | 0.060 |
Why?
|
| Social Behavior Disorders | 1 | 2000 | 5 | 0.060 |
Why?
|
| Home Nursing | 1 | 2000 | 21 | 0.060 |
Why?
|
| Administration, Topical | 2 | 2011 | 30 | 0.060 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2000 | 64 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2000 | 34 | 0.050 |
Why?
|
| Neuropsychological Tests | 4 | 2003 | 223 | 0.050 |
Why?
|
| Regression (Psychology) | 1 | 1999 | 4 | 0.050 |
Why?
|
| Nitrates | 1 | 1999 | 14 | 0.050 |
Why?
|
| Office Visits | 1 | 1999 | 25 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2011 | 472 | 0.050 |
Why?
|
| Vitamin B Complex | 2 | 1996 | 18 | 0.050 |
Why?
|
| Occupational Health Services | 1 | 1999 | 43 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 1999 | 49 | 0.050 |
Why?
|
| Body Height | 1 | 1998 | 97 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 1999 | 165 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 1998 | 30 | 0.050 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1998 | 36 | 0.050 |
Why?
|
| Survival Rate | 2 | 2015 | 491 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 1998 | 78 | 0.050 |
Why?
|
| Thrombosis | 1 | 1999 | 125 | 0.050 |
Why?
|
| Matched-Pair Analysis | 1 | 2017 | 10 | 0.050 |
Why?
|
| Classification | 1 | 2017 | 8 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 1998 | 125 | 0.050 |
Why?
|
| Social Behavior | 2 | 2009 | 64 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2012 | 218 | 0.040 |
Why?
|
| Lipoprotein(a) | 1 | 1996 | 7 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 1996 | 2 | 0.040 |
Why?
|
| Self Disclosure | 1 | 1996 | 41 | 0.040 |
Why?
|
| Fibrinogen | 1 | 1996 | 35 | 0.040 |
Why?
|
| Peritoneal Dialysis | 1 | 1996 | 13 | 0.040 |
Why?
|
| Linear Models | 1 | 2017 | 339 | 0.040 |
Why?
|
| Diet Surveys | 1 | 1996 | 63 | 0.040 |
Why?
|
| Folic Acid | 1 | 1996 | 36 | 0.040 |
Why?
|
| Quality Control | 2 | 2010 | 48 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 204 | 0.040 |
Why?
|
| Urban Health | 1 | 2015 | 47 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 2015 | 27 | 0.040 |
Why?
|
| Injections | 1 | 2015 | 56 | 0.040 |
Why?
|
| African Continental Ancestry Group | 3 | 2001 | 146 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 1995 | 41 | 0.040 |
Why?
|
| Restraint, Physical | 2 | 2008 | 29 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1995 | 31 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 121 | 0.040 |
Why?
|
| Diet | 2 | 1995 | 456 | 0.040 |
Why?
|
| Self Concept | 1 | 2014 | 90 | 0.040 |
Why?
|
| Publication Bias | 1 | 2013 | 11 | 0.040 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2013 | 19 | 0.040 |
Why?
|
| Demography | 2 | 2007 | 156 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 167 | 0.030 |
Why?
|
| Trichuris | 1 | 2012 | 21 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2012 | 44 | 0.030 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2005 | 64 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 535 | 0.030 |
Why?
|
| Schools | 1 | 2012 | 97 | 0.030 |
Why?
|
| Ireland | 1 | 2011 | 14 | 0.030 |
Why?
|
| Students | 1 | 2012 | 124 | 0.030 |
Why?
|
| Morbidity | 2 | 2000 | 49 | 0.030 |
Why?
|
| Observer Variation | 1 | 2010 | 150 | 0.030 |
Why?
|
| Blood Pressure | 3 | 1996 | 367 | 0.030 |
Why?
|
| Verbal Behavior | 1 | 2009 | 30 | 0.030 |
Why?
|
| Leisure Activities | 1 | 2009 | 26 | 0.030 |
Why?
|
| Ear Neoplasms | 1 | 2009 | 7 | 0.030 |
Why?
|
| Facial Neoplasms | 1 | 2009 | 8 | 0.030 |
Why?
|
| Teaching | 1 | 2010 | 148 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2009 | 94 | 0.020 |
Why?
|
| Aggression | 1 | 2009 | 67 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 40 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 2008 | 32 | 0.020 |
Why?
|
| Heart Diseases | 2 | 2000 | 140 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 638 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 147 | 0.020 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2007 | 9 | 0.020 |
Why?
|
| Financing, Personal | 1 | 2007 | 17 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2007 | 73 | 0.020 |
Why?
|
| Condoms | 1 | 2007 | 41 | 0.020 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2007 | 177 | 0.020 |
Why?
|
| Narcotics | 1 | 2006 | 32 | 0.020 |
Why?
|
| Clozapine | 1 | 2005 | 30 | 0.020 |
Why?
|
| Arteriosclerosis | 2 | 1996 | 35 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2005 | 63 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2005 | 47 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 125 | 0.020 |
Why?
|
| Sex Offenses | 1 | 2004 | 19 | 0.020 |
Why?
|
| Interdepartmental Relations | 1 | 2004 | 1 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 2004 | 52 | 0.020 |
Why?
|
| Decision Making, Organizational | 1 | 2004 | 26 | 0.020 |
Why?
|
| Brain | 1 | 2010 | 844 | 0.020 |
Why?
|
| Child Abuse | 1 | 2004 | 55 | 0.020 |
Why?
|
| Population | 1 | 2003 | 13 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2003 | 16 | 0.020 |
Why?
|
| Leadership | 1 | 2004 | 79 | 0.020 |
Why?
|
| Preventive Medicine | 1 | 2003 | 37 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 47 | 0.020 |
Why?
|
| Mississippi | 1 | 2002 | 16 | 0.020 |
Why?
|
| Diphosphonates | 1 | 2002 | 32 | 0.020 |
Why?
|
| Public Policy | 1 | 2001 | 26 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 2001 | 42 | 0.010 |
Why?
|
| Iceland | 1 | 2000 | 5 | 0.010 |
Why?
|
| Denmark | 1 | 2000 | 9 | 0.010 |
Why?
|
| Sweden | 1 | 2000 | 21 | 0.010 |
Why?
|
| Japan | 1 | 2000 | 26 | 0.010 |
Why?
|
| Italy | 1 | 2000 | 44 | 0.010 |
Why?
|
| Clinical Enzyme Tests | 1 | 2000 | 6 | 0.010 |
Why?
|
| Regional Medical Programs | 1 | 2000 | 4 | 0.010 |
Why?
|
| Biotransformation | 1 | 2000 | 12 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2000 | 40 | 0.010 |
Why?
|
| Autopsy | 1 | 2000 | 25 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2000 | 38 | 0.010 |
Why?
|
| Confusion | 1 | 2000 | 11 | 0.010 |
Why?
|
| Hallucinations | 1 | 2000 | 14 | 0.010 |
Why?
|
| Calcium | 1 | 2002 | 472 | 0.010 |
Why?
|
| Methionine | 1 | 1999 | 43 | 0.010 |
Why?
|
| Diagnosis | 1 | 1999 | 8 | 0.010 |
Why?
|
| Information Systems | 1 | 1999 | 25 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2000 | 293 | 0.010 |
Why?
|
| Metabolic Diseases | 1 | 1999 | 32 | 0.010 |
Why?
|
| Mental Health | 1 | 1999 | 101 | 0.010 |
Why?
|
| Health Policy | 1 | 1999 | 127 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 169 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1998 | 145 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1997 | 57 | 0.010 |
Why?
|
| Epidemiologic Factors | 1 | 1996 | 5 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 1996 | 12 | 0.010 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1996 | 11 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1996 | 26 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 1996 | 18 | 0.010 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 1996 | 20 | 0.010 |
Why?
|
| Creatinine | 1 | 1996 | 85 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1996 | 139 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 1996 | 61 | 0.010 |
Why?
|
| Colorado | 1 | 1995 | 12 | 0.010 |
Why?
|
| Embolism, Cholesterol | 1 | 1995 | 1 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1995 | 20 | 0.010 |
Why?
|
| Serine | 1 | 1995 | 63 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1996 | 105 | 0.010 |
Why?
|
| Treatment Refusal | 1 | 1995 | 43 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2000 | 862 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2000 | 1008 | 0.010 |
Why?
|
| Exercise Test | 1 | 1995 | 156 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1995 | 171 | 0.010 |
Why?
|
| Mental Recall | 1 | 1994 | 112 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1993 | 15 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 1993 | 66 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 1442 | 0.010 |
Why?
|
| Acute Disease | 1 | 1993 | 523 | 0.010 |
Why?
|